Eli Lilly says its experimental gene-editing therapy VERVE-102 significantly lowered LDL cholesterol levels in an early clinical trials
Go to Source
Author: News18
Go to Source
Author: News18
Hot this week
Free News - Where voices unite, stories flourish, and community thrives through open dialogue and meaningful connections.
Get important news delivered directly to your inbox and stay connected!
